The Nordic urinary catheters market size in 2026 is witnessing steady growth as healthcare systems across the region respond to the increasing prevalence of urinary incontinence, rising geriatric population, growing number of surgeries, and expanding healthcare infrastructure. Urinary catheters are medical devices inserted into the bladder through the urethra to allow urine to drain from the bladder for collection. These products are used for managing conditions associated with urinary incontinence and urinary retention.

According to Fortune Business Insights, the global nordic urinary catheters market size was valued at USD 82.11 million in 2025. The market is projected to expand from USD 87.20 million in 2026 to USD 141.09 million by 2034, growing at a CAGR of 6.20% over the forecast period. Sweden dominated the Nordic urinary catheters market with a market share of 35.74% in 2025.

Urinary catheters are used across healthcare settings to facilitate urine drainage when patients experience urinary retention or urinary incontinence and during selected medical and surgical procedures. The Nordic market includes indwelling, intermittent, and external catheters. Intermittent catheterization is considered the gold standard and is preferred over indwelling catheterization because its short-term use can reduce the risk of catheter-associated urinary tract infections. The market is also influenced by demographic changes across Nordic countries. The growing elderly population is expected to increase demand for urinary catheters, as urinary incontinence and other urological conditions become more prevalent with age. In Sweden, about 20% of citizens had passed the standard retirement age of 65 in 2022, and this proportion was projected to reach 23% by 2040.

Top Companies In The Market

• BACTIGUARD AB

• Coloplast A/S

• Convatec Group PLC

• Hollister Incorporated

• Boston Scientific Corporation

• BD (Becton, Dickinson and Company)

• B. Braun SE

• Wellspect HealthCare (Dentsply Sirona)

Market Drivers & Restraints

One of the major factors supporting the Nordic urinary catheters market growth is the rising prevalence of urinary incontinence and other medical conditions. Urinary incontinence among men can be associated with conditions such as an enlarged prostate, diabetes, Parkinson's disease, and prostate surgery. Among women, urinary incontinence can occur during pregnancy, following childbirth, and after hormonal changes during menopause. The increasing prevalence of these conditions is expected to support demand for indwelling, external, and intermittent catheters.

The aging population across Nordic countries is another important growth factor. The growing number of elderly individuals is increasing the need for healthcare products used to manage urinary conditions. In addition, the increasing number of urological and gynecological surgeries is expected to contribute to product adoption. Urinary catheterization is used during cardiac surgeries and other procedures to facilitate urine drainage and monitor urine output.

However, the market faces restraints associated with catheter-associated urinary tract infections and social stigma. Long-term use of indwelling urinary catheters can increase the risk of catheter-associated infections, which may limit adoption. Concerns surrounding healthcare-associated urinary tract infections and embarrassment associated with urinary conditions may also affect product utilization.

Market Competitive Landscape

The competitive landscape of the Nordic urinary catheters market is fragmented, with several established companies holding significant market positions. Coloplast A/S, Wellspect HealthCare (Dentsply Sirona), BACTIGUARD, B. Braun SE, and ConvaTec are among the prominent companies supported by established market presence, product portfolios, distribution networks, and product development activities.

Companies are focusing on strategic initiatives, innovative products, product portfolio expansion, and distribution capabilities to strengthen their presence across Nordic countries. Wellspect HealthCare received a Nordic Swan label license for its LoFric catheter range in April 2022. In April 2023, the company also introduced bioplastic into its LoFric Elle female urinary catheter, replacing conventional fossil-based raw material and reducing its carbon footprint by 55%.

Market Segments

By Product (Indwelling Catheters, Intermittent Catheters, and External Catheters)

By Application (Urinary Incontinence, Spinal Cord Injury, Gynecology, Benign Prostatic Hyperplasia, Surgery, and Others)

By Gender (Male and Female),

By End-User (Hospitals, Age Care Centers, and Others)

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/nordic-urinary-catheters-market-108559 

Market Regional Insights

The Nordic urinary catheters market is segmented geographically into Sweden, Norway, Denmark, Finland, and the Rest of Nordic. Sweden dominated the market with a valuation of USD 29.35 million in 2025 and is projected to reach USD 31.16 million in 2026. The country's market is supported by increasing patient admissions, longer hospital stays, chronic diseases, insurance facilities, and surgical procedures.

Norway held a sizeable market share due to improved healthcare facilities, higher adoption of urinary catheters, and healthcare demand. Denmark, Finland, and the Rest of Nordic are also witnessing market growth due to improved healthcare infrastructure, reimbursement facilities, and rising adoption of urinary catheters for the needs of elderly patients.

Future Market Scope

The future scope of the Nordic urinary catheters market is associated with technological advancements, increasing adoption of innovative products, demographic changes, and growing healthcare requirements. Companies are increasingly investing in advanced catheter technologies and sustainable raw materials. Coloplast launched the Luja male intermittent catheter in February 2023, featuring more than 80 micro-holes designed to reduce the risk of urinary tract infections.

Sustainability is also emerging as an important area of product development. Wellspect HealthCare's use of bioplastic in LoFric Elle demonstrates efforts toward sustainable catheter manufacturing. The introduction of technologically advanced products, increasing elderly population, rising prevalence of urinary incontinence, and growing surgical requirements are expected to support the continued expansion of the Nordic urinary catheters market through 2034.

What’s Driving Japan’s Market? Discover the Latest -Nordic Urinary Catheters Market- Insights